Balaji Amines Ltd
Balaji Amines Ltd specialises in manufacturing Methylamines, Ethylamines, Derivatives of specialty chemicals and Pharma Excipients. These have been the main products, it also have facilities for the manufacturing of derivatives, which are down-stream products for various pharma/pesticide industries apart from user specific requirements. It is one of the largest manufacturers of aliphatic amines in India. [1]
- Market Cap ₹ 7,214 Cr.
- Current Price ₹ 2,228
- High / Low ₹ 2,736 / 1,873
- Stock P/E 39.2
- Book Value ₹ 496
- Dividend Yield 0.45 %
- ROCE 36.5 %
- ROE 23.2 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 23.6% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 28.6%
- Debtor days have improved from 79.0 to 58.8 days.
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
447 | 509 | 608 | 616 | 640 | 668 | 858 | 940 | 935 | 1,308 | 2,314 | 2,346 | 1,699 | |
367 | 429 | 517 | 515 | 514 | 519 | 676 | 747 | 754 | 935 | 1,691 | 1,736 | 1,380 | |
Operating Profit | 81 | 80 | 91 | 102 | 127 | 149 | 182 | 193 | 181 | 373 | 623 | 609 | 319 |
OPM % | 18% | 16% | 15% | 17% | 20% | 22% | 21% | 21% | 19% | 29% | 27% | 26% | 19% |
4 | 4 | 3 | 4 | 3 | 9 | 12 | 4 | 5 | 6 | 15 | 15 | 26 | |
Interest | 21 | 25 | 32 | 35 | 22 | 13 | 9 | 13 | 23 | 18 | 17 | 12 | 8 |
Depreciation | 10 | 13 | 16 | 20 | 19 | 20 | 19 | 20 | 32 | 34 | 42 | 46 | 44 |
Profit before tax | 53 | 46 | 46 | 51 | 88 | 126 | 166 | 165 | 131 | 327 | 578 | 567 | 294 |
Tax % | 32% | 32% | 27% | 35% | 34% | 34% | 32% | 29% | 26% | 25% | 28% | 28% | |
36 | 31 | 34 | 33 | 58 | 82 | 113 | 117 | 97 | 243 | 418 | 406 | 215 | |
EPS in Rs | 11.00 | 9.62 | 10.34 | 10.25 | 17.78 | 25.42 | 34.93 | 36.27 | 32.34 | 73.51 | 113.71 | 100.47 | 56.85 |
Dividend Payout % | 7% | 14% | 10% | 12% | 11% | 9% | 7% | 8% | 10% | 5% | 5% | 10% |
Compounded Sales Growth | |
---|---|
10 Years: | 17% |
5 Years: | 22% |
3 Years: | 36% |
TTM: | -36% |
Compounded Profit Growth | |
---|---|
10 Years: | 27% |
5 Years: | 24% |
3 Years: | 49% |
TTM: | -52% |
Stock Price CAGR | |
---|---|
10 Years: | 49% |
5 Years: | 38% |
3 Years: | 5% |
1 Year: | 2% |
Return on Equity | |
---|---|
10 Years: | 25% |
5 Years: | 26% |
3 Years: | 29% |
Last Year: | 23% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
Reserves | 139 | 165 | 195 | 221 | 274 | 356 | 461 | 568 | 652 | 888 | 1,243 | 1,548 | 1,602 |
216 | 209 | 262 | 256 | 173 | 105 | 152 | 227 | 260 | 127 | 101 | 58 | 44 | |
105 | 139 | 158 | 139 | 152 | 168 | 229 | 244 | 195 | 289 | 395 | 351 | 337 | |
Total Liabilities | 466 | 519 | 620 | 623 | 605 | 635 | 848 | 1,046 | 1,113 | 1,310 | 1,745 | 1,963 | 1,989 |
196 | 234 | 325 | 341 | 341 | 325 | 316 | 320 | 573 | 543 | 681 | 780 | 771 | |
CWIP | 25 | 63 | 8 | 3 | 16 | 25 | 123 | 269 | 46 | 173 | 141 | 113 | 196 |
Investments | 8 | 20 | 20 | 0 | 0 | 0 | 0 | 0 | 48 | 0 | 0 | 73 | 0 |
237 | 202 | 267 | 278 | 248 | 284 | 409 | 457 | 446 | 594 | 923 | 996 | 1,023 | |
Total Assets | 466 | 519 | 620 | 623 | 605 | 635 | 848 | 1,046 | 1,113 | 1,310 | 1,745 | 1,963 | 1,989 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
53 | 94 | 111 | 56 | 85 | 60 | 140 | 94 | 144 | 110 | 220 | 382 | |
-56 | -86 | -50 | -4 | -29 | -10 | -135 | -119 | -130 | -62 | -147 | -186 | |
-1 | -10 | -53 | -55 | -54 | -55 | 16 | 21 | -26 | -37 | -57 | -81 | |
Net Cash Flow | -5 | -2 | 7 | -3 | 2 | -5 | 21 | -4 | -12 | 11 | 16 | 115 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 67 | 74 | 79 | 71 | 71 | 68 | 73 | 65 | 81 | 85 | 93 | 59 |
Inventory Days | 149 | 66 | 87 | 114 | 80 | 106 | 70 | 116 | 77 | 64 | 66 | 89 |
Days Payable | 48 | 42 | 83 | 48 | 58 | 55 | 56 | 60 | 42 | 44 | 54 | 18 |
Cash Conversion Cycle | 168 | 99 | 83 | 136 | 93 | 119 | 87 | 120 | 116 | 104 | 105 | 129 |
Working Capital Days | 121 | 75 | 67 | 95 | 70 | 78 | 74 | 89 | 102 | 91 | 94 | 94 |
ROCE % | 23% | 19% | 18% | 18% | 23% | 30% | 32% | 24% | 18% | 35% | 49% | 36% |
Documents
Announcements
-
Certificate Under Regulations 40(9) Of SEBI (LODR) Regulations, 2015
19 Apr - Certificate under Regulation 40(9) of SEBI (LODR) Regulations, 2015 for the year ended 31st March, 2024
-
Compliances-Compliance Certificate For The Period Ended 31St March, 2024
11 Apr - Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulations, 2015
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
3 Apr - Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2024
- Closure of Trading Window 29 Mar
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 14 Mar
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2011
from nse
-
Financial Year 2010
from bse
Concalls
-
Feb 2024TranscriptNotesPPT
-
Nov 2023Transcript PPT
-
Sep 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023TranscriptNotesPPT
-
Oct 2022TranscriptNotesPPT
-
Aug 2022TranscriptNotesPPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Jun 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Aug 2020Transcript PPT
-
Jul 2020Transcript PPT
-
Feb 2020Transcript PPT
-
Jan 2020TranscriptNotesPPT
-
Dec 2019Transcript PPT
-
Nov 2019TranscriptNotesPPT
-
Aug 2019Transcript PPT
-
Jul 2019TranscriptNotesPPT
-
May 2019TranscriptPPT
-
Aug 2018TranscriptPPT
-
May 2018TranscriptPPT
-
Feb 2018TranscriptPPT
-
Feb 2017TranscriptPPT
-
Feb 2017TranscriptPPT
Product Portfolio[1]
The company has a diversified product portfolio with a basket of over 30 different products. These products are categorised under 3 main categories i.e. Amines, Amine derivatives and Specialty & Other chemicals. Its products includes Methyl Amines, Ethyl amines, Amino Ethanol, acetamide, amine hydrochloride, methyl urea, choline chloride, morpholine, etc.
Its products find application in many industries like Pharma, Agro, Rubber chemicals, photographic chemicals, rocket fuel, pesticides, solvents, performance chemicals, water treatment chemicals, etc.